HTT and Huntington disease: One approach to HTT lowering in clinical studies in HD patients involves small-molecule RNA-splicing modulators which induce nonsense-mediated decay of HTT transcript, reducing both WT and mutant HTT proteins (Bhattacharyya et al, 2021; Keller et al, 2022).